Al Razi Medical Company vs Al Dawaa Medical Services Co.
A head-to-head of Al Razi Medical Company (9572) and Al Dawaa Medical Services Co. (4163) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 9572 | 4163 |
|---|---|---|
| Market Cap | 43.05M SAR | 3.68B SAR |
| P/E (TTM) | 58.85 | 10.82 |
| Forward P/E | — | 7.85 |
| P/S | 0.58 | 0.55 |
| P/B | 2.06 | 2.44 |
| EV/EBITDA | 16.74 | 10.76 |
| Dividend Yield | — | 6.13% |
| Profit Margin | 1.10% | 3.61% |
| Gross Margin | 25.94% | 35.23% |
| Operating Margin | 2.65% | 7.20% |
| Revenue Growth (YoY) | +34.00% | -6.38% |
| FCF Yield | — | 12.89% |
| Debt / Equity | 11.78 | 37.04 |
| Current Ratio | 1.47 | 1.18 |
Which is better: Al Razi Medical Company or Al Dawaa Medical Services Co.?
- ✓Larger by market cap: Al Dawaa Medical Services Co.
- ✓Cheaper valuation (lower P/E): Al Dawaa Medical Services Co.
- ✓More profitable (net margin): Al Dawaa Medical Services Co.
- ✓Faster revenue growth: Al Razi Medical Company
Across 10 available metrics, Al Dawaa Medical Services Co. leads 6–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Al Razi Medical Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.